Nilotinib in locally advanced pigmented villonodular synovitis: A multicentre, open-label, single-arm, phase 2 trial

March 23, 2018

Nilotinib in locally advanced pigmented villonodular synovitis: A multicentre, open-label, single-arm, phase 2 trial

Published on 03/22/2018

previous post: Mycophenolate plus methylprednisolone vs methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): A randomised, observer-masked, multicentre trial
next post: Pediatric tonsil cancer: A national and institutional perspective